Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 9

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 9
---
 Class A common stock in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other agent has discretionary authority under NYSE rules to vote your shares on this proposal. Abstentions will have no effect. For Proposal 3, approval, on an advisory basis, of the compensation of the Company’s named executive officers, must receive “For” votes from the holders of a majority of voting power of the shares of Class A common stock present virtually or represented by proxy and voting affirmatively or negatively (excluding abstentions and broker non-votes) on the matter. Abstentions and broker non-votes will have no effect. For Proposal 4, to indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers, the proposed voting frequency that receives affirmative votes from the holders of a majority of voting power of the shares of Class A common stock present virtually or represented by proxy and voting affirmatively or negatively (excluding abstentions and broker non-votes) on the 5 TABLE OF CONTENTS matter. If none of the proposed voting frequencies receives affirmative votes from the holders of a majority of the voting power of the shares of Class A common stock present virtually or represented by proxy and voting on the matter, the Company will consider the frequency receiving the highest number of affirmative votes to be the frequency preferred by our stockholders. Abstentions and broker non-votes will have no effect. What is the quorum requirement? A quorum of stockholders is necessary to hold a valid meeting. The presence, in person, by remote communication, if applicable, or by proxy, of the holders of a majority of the voting power of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction of business. On the Record Date, there were 63,771,720 shares of Class A common stock outstanding and entitled to vote. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the chair of the Annual Meeting or the holders of a majority of voting power of the shares of Class A common stock represented thereat and entitled to vote thereon may adjourn the meeting to another date. How can I find out the results of the voting at the Annual Meeting? Preliminary voting results are expected to be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that